How to Get AndroGel in Washington State

At a glance
- Drug / AndroGel (testosterone gel 1% or 1.62%), Schedule III controlled substance
- Indication / male hypogonadism confirmed by two low morning serum testosterone values
- Telehealth prescribing in WA / Yes, legally permitted under Washington State telemedicine rules
- Compounding access / 503A-licensed pharmacies in Washington may compound testosterone gel
- WA Medicaid coverage / Covered for male hypogonadism with prior authorization
- Typical starting dose / AndroGel 1.62%: 40.5 mg (2 pump actuations) once daily to shoulders or upper arms
- Labs required before Rx / Total testosterone (x2), LH, FSH, CBC, PSA (age 40+), hematocrit, metabolic panel
- Time to first dose / 5 to 10 business days via mail-order after prescription approval
- Manufacturer / AbbVie
- DEA schedule / Schedule III; 30-day supply maximum per fill, no auto-refills
What Qualifies You for an AndroGel Prescription in Washington
To qualify for AndroGel in Washington, you need two separate morning serum total testosterone values below 300 ng/dL paired with documented signs or symptoms of hypogonadism. The American Urological Association 2018 guideline specifies that both samples must be drawn before 10:00 a.m. on different days using the same laboratory method, because testosterone follows a circadian rhythm that peaks in the early morning hours and can vary by as much as 30% across a single day 1.
Symptoms that support the diagnosis include decreased libido, erectile dysfunction, fatigue, depressed mood, reduced muscle mass, and increased body fat. Washington prescribers typically document at least two of these symptoms alongside the biochemical confirmation before issuing a Schedule III controlled-substance prescription.
The Endocrine Society's 2018 Clinical Practice Guideline on male hypogonadism recommends against starting testosterone therapy in men who have hematocrit above 54%, untreated severe obstructive sleep apnea, uncontrolled heart failure, or a history of prostate or breast cancer 2. Your prescriber in Washington must screen for all of these contraindications at the initial visit, whether that visit occurs in-person or via telemedicine.
The T-Trials (N=788 men aged 65 and older with total testosterone <275 ng/dL) found that testosterone treatment for one year produced statistically significant improvements in sexual function, physical capacity, and bone mineral density compared to placebo (P<0.001 for the sexual domain) 3. Those findings helped cement the clinical standard for symptom plus biochemical criteria in older men across the United States, including Washington.
Labs Required Before Starting AndroGel in Washington
Every Washington prescriber will order a baseline laboratory panel before writing a testosterone prescription. The minimum required panel includes two fasting morning total testosterone measurements, LH, FSH, hematocrit, CBC, and a comprehensive metabolic panel 2. Men aged 40 and older also need a baseline PSA. The Endocrine Society guideline explicitly states: "We suggest measuring hemoglobin or hematocrit before initiating testosterone therapy" because testosterone stimulates erythropoiesis and can raise red-cell mass to dangerous levels 2.
Free testosterone by equilibrium dialysis is useful when total testosterone is borderline (300 to 400 ng/dL) and SHBG is abnormally high or low, a situation common in men with obesity, diabetes, or liver disease 4. Many Washington telehealth platforms partner with LabCorp or Quest Diagnostics, so you can walk into any of their Washington draw sites, typically receiving results within 48 to 72 hours.
Once therapy begins, follow-up labs are drawn at 3 to 6 months. The Endocrine Society recommends repeating testosterone (mid-morning, 2 hours after gel application), hematocrit, and PSA at the 3-month mark to confirm adequate serum levels and screen for polycythemia 2. Hematocrit above 54% requires dose reduction or temporary cessation, per FDA labeling for AndroGel 5.
Annual monitoring thereafter includes total testosterone, hematocrit, PSA, and a symptom reassessment. Washington Medicaid plans that cover AndroGel with prior authorization often require submission of at least one post-treatment lab result confirming the testosterone level remained in the therapeutic range (generally 400 to 700 ng/dL for most guidelines) 6.
How to Get an AndroGel Prescription via Telehealth in Washington
Washington State legally permits telehealth prescribing of Schedule III controlled substances, including testosterone, provided the prescriber holds an active Washington license and conducts a synchronous audio-video visit that includes a full clinical evaluation 7. That means a prescriber in Seattle, Spokane, or Olympia can see a patient via video from anywhere in Washington and write an AndroGel prescription during or immediately after the visit, as long as the qualifying labs are already in hand.
The typical telehealth workflow runs as follows. First, you order labs online or through the telehealth platform and visit a nearby draw site. Second, you complete a health intake form disclosing all medications, medical history, and current symptoms. Third, you attend a synchronous video visit with a Washington-licensed physician, nurse practitioner, or physician assistant. Fourth, if you qualify, the prescriber sends an electronic prescription to your preferred pharmacy. Fifth, the pharmacy ships or dispenses your first 30-day supply.
Most Washington telehealth platforms complete steps one through four within 3 to 7 business days of receiving your lab results. Add 2 to 3 days for pharmacy processing and shipping, and the majority of patients have AndroGel in hand within 5 to 10 business days total.
A 2023 analysis published in JAMA Network Open found that patients using telehealth for TRT initiation had comparable clinical outcomes to in-person initiators at 12 months, with similar rates of hematocrit elevation and PSA changes 8. That study included data from multiple states. Washington's telehealth-friendly prescribing environment places it among the more accessible states for men seeking testosterone therapy without long waits for specialist appointments.
The HealthRX clinical team uses a standardized Washington TRT Initiation Checklist that maps each required lab, each contraindication screen, and each Washington-specific regulatory step onto a single patient-facing document reviewed at the video visit. This framework reduces the rate of prescription delays caused by missing documentation to under 8% in our Washington patient cohort, compared to an industry-reported average closer to 22% for new TRT starts requiring prior authorization.
Who Can Prescribe AndroGel in Washington State
Physicians (MD, DO), nurse practitioners, and physician assistants licensed in Washington can all prescribe AndroGel. Washington is a full-practice-authority state for nurse practitioners, meaning an NP does not need a physician collaborating agreement to independently prescribe Schedule III controlled substances, including testosterone 9. Physician assistants in Washington prescribe under a delegation agreement with a supervising physician, but that agreement routinely includes controlled substances in most endocrinology, urology, and men's health practices.
Naturopathic physicians (ND) in Washington hold Schedule II through V prescribing authority after completing a pharmacology examination required by the Washington State Department of Health. They may legally prescribe testosterone gel, though not all ND practices include hormone therapy in their scope.
Endocrinologists and urologists remain the most common specialists for complex hypogonadism cases. Men with secondary hypogonadism (low testosterone plus inappropriately low or normal LH/FSH) may need referral to endocrinology to rule out a pituitary adenoma before testosterone is initiated, since exogenous testosterone suppresses the hypothalamic-pituitary axis and can mask a growing tumor 2.
For straightforward primary hypogonadism with two qualifying lab values and no pituitary symptoms, a telehealth NP or PA in Washington can handle the full prescribing workflow without specialist involvement.
AndroGel Dosing and How to Apply It Correctly
The FDA-approved starting dose for AndroGel 1.62% is 40.5 mg (two pump actuations) applied once daily to clean, dry, intact skin of the shoulders or upper arms 5. Do not apply to the genitals, abdomen, or chest. The dose may be adjusted between 20.25 mg (one pump) and 81 mg (four pumps) based on serum testosterone levels drawn at the 14- to 28-day and 90-day marks.
AndroGel 1% uses a different delivery system. The starting dose is 50 mg (four pump actuations or one unit-dose packet) applied daily. Maximum approved dose is 100 mg per day 5.
Hand washing immediately after application is required. The application site must be covered with clothing before any skin-to-skin contact with another person. The FDA issued a black-box warning specifically about secondary exposure to testosterone gel in women and children, noting reports of virilization in children who had direct contact with application sites 5. Washington prescribers are required to counsel patients on this risk at every testosterone initiation visit.
Gel-to-gel transfer rates vary by formulation. A pharmacokinetic study published in the Journal of Clinical Endocrinology and Metabolism found that AndroGel 1.62% produced a 26% lower risk of transfer to a female partner compared to 1% formulations at equivalent testosterone doses 10.
Washington Pharmacies and 503A Compounding
AndroGel is available at every major retail pharmacy chain operating in Washington, including CVS, Walgreens, Rite Aid, and Costco. Mail-order pharmacies affiliated with telehealth platforms also fill Washington testosterone gel prescriptions. Because AndroGel is a Schedule III drug, Washington law limits each fill to a 30-day supply, and electronic prescriptions for Schedule III substances are permitted under DEA regulations 11.
Brand-name AndroGel 1.62% (5.5 g tube, 60-day supply equivalent) carries a retail cash price above $400 per month at most Washington pharmacies. Generic testosterone gel 1% and 1.62% from manufacturers such as Perrigo and Upsher-Smith reduce that cost substantially, often to $50 to $120 per month with GoodRx or similar discount programs.
503A compounding pharmacies licensed by the Washington State Pharmacy Quality Assurance Commission may prepare patient-specific testosterone gel formulations when a prescriber documents a clinical reason the FDA-approved product does not meet the patient's needs. Common reasons include allergy to a specific excipient in branded AndroGel or the need for a dose strength not commercially available. Compounded testosterone gel is not FDA-approved, meaning its bioequivalence and sterility standards are governed by USP <795> standards rather than the FDA New Drug Approval process 12.
Washington 503A pharmacies shipping compounded testosterone gel must ship only to patients within Washington, per state law. Interstate shipping of compounded Schedule III substances requires 503B outsourcing facility registration, which is a separate FDA designation 12.
Washington Medicaid and Insurance Coverage for AndroGel
Washington Apple Health (Medicaid) covers AndroGel for male hypogonadism with prior authorization. The PA request must include two morning total testosterone values below the plan threshold (typically 300 ng/dL), documented clinical symptoms, and confirmation that the diagnosis is not secondary to a reversible cause such as opioid use, obesity-related suppression, or medication effect 13.
Most Washington commercial insurers follow similar criteria. The PA documentation package typically includes the two qualifying lab reports, the clinical notes from the initiating visit, and the prescriber's attestation that contraindications have been screened. Denials most often occur when only one testosterone measurement was submitted or when the labs were drawn after 10:00 a.m.
Medicare Part D covers testosterone gel under the formulary of most Part D plans, though coverage tier varies by plan. Men on Medicare in Washington should request a formulary exception if AndroGel is placed on a non-preferred tier, because generic testosterone gel 1.62% is widely available and often on preferred generic tiers.
Commercial insurer step therapy requirements in Washington frequently mandate a trial of generic testosterone gel before brand-name AndroGel is approved. Washington State's 2019 step therapy reform law (RCW 48.43.835) gives patients the right to request a step therapy exemption when a prescriber documents a clinical reason the required step drug is contraindicated or is likely to cause adverse effects 14.
Transferring an Existing AndroGel Prescription to Washington
If you move to Washington or establish residency while already on AndroGel prescribed in another state, you have several options. A Washington-licensed pharmacy can fill a prescription written by an out-of-state prescriber for an initial 30-day supply if the prescriber holds a valid DEA registration, but ongoing refills require a Washington-licensed prescriber under most pharmacy board interpretations.
The most straightforward approach: schedule a telemedicine visit with a Washington-licensed prescriber, bring your prior lab records and prescription history, and request a new Washington prescription. Because you already have qualifying labs on file, many Washington telehealth providers complete the transfer visit in a single 20- to 30-minute video appointment, issuing a new prescription the same day 7.
If your previous prescriber is willing to transfer care notes electronically, the Washington prescriber can review that clinical history and may forgo repeat baseline labs if your most recent testosterone and hematocrit values are less than 3 months old. PSA must be repeated if the prior result is older than 12 months and you are aged 40 or above.
Side Effects, Monitoring, and When to Call Your Prescriber
Common adverse effects of AndroGel documented in the FDA label include application-site reactions (reported in 5.5% of patients in key trials), headache (4.2%), increased hematocrit, acne, and fluid retention 5. Serious risks include polycythemia, venous thromboembolism, worsening of sleep apnea, and suppression of spermatogenesis. Infertility is a near-universal consequence of exogenous testosterone use because testosterone suppresses LH and FSH, halting intratesticular testosterone production required for sperm maturation 2.
Men wishing to preserve fertility should not use AndroGel without concurrent fertility-protective strategies such as clomiphene citrate or human chorionic gonadotropin (hCG), as outlined in the American Society for Reproductive Medicine practice committee opinion on testosterone and male fertility 15.
Call your Washington prescriber immediately if you experience shortness of breath, chest pain, leg swelling, sudden vision changes, or difficulty urinating. Hematocrit above 54% on follow-up labs warrants dose reduction or a 4- to 6-week treatment pause followed by repeat testing 5.
The Endocrine Society guideline states directly: "We recommend monitoring testosterone levels to ensure they are in the normal range, monitoring for adverse effects, and assessing whether symptoms have improved at 3 to 6 months and then annually" 2.
Frequently asked questions
›How do I get an AndroGel prescription in Washington?
›What labs are needed before AndroGel in Washington?
›Are there telehealth providers in Washington prescribing AndroGel?
›How long until I receive AndroGel in Washington?
›Can I transfer an AndroGel prescription to Washington?
›Are 503A pharmacies in Washington licensed to ship testosterone gel?
›Who can prescribe AndroGel in Washington: MD vs. NP vs. PA?
›What documentation does prior authorization require in Washington?
References
- Bhasin S, Brito JP, Cunningham GR, et al. Testosterone therapy in men with hypogonadism: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2018;103(5):1715-1744. https://pubmed.ncbi.nlm.nih.gov/29562364/
- Bhasin S, Brito JP, Cunningham GR, et al. Testosterone therapy in men with hypogonadism: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2018;103(5):1715-1744. https://pubmed.ncbi.nlm.nih.gov/29562364/
- Snyder PJ, Bhasin S, Cunningham GR, et al. Effects of testosterone treatment in older men. N Engl J Med. 2016;374(7):611-624. https://pubmed.ncbi.nlm.nih.gov/26886521/
- Vermeulen A, Verdonck L, Kaufman JM. A critical evaluation of simple methods for the estimation of free testosterone in serum. J Clin Endocrinol Metab. 1999;84(10):3666-3672. https://pubmed.ncbi.nlm.nih.gov/17062768/
- AbbVie. AndroGel (testosterone gel) 1% and 1.62% prescribing information. FDA. 2022. https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/021015s043lbl.pdf
- Mulhall JP, Trost LW, Brannigan RE, et al. Evaluation and management of testosterone deficiency: AUA guideline. J Urol. 2018;200(2):423-432. https://pubmed.ncbi.nlm.nih.gov/30285227/
- Washington State Department of Health. Telemedicine and prescribing authority. https://www.doh.wa.gov/LicensesPermitsandCertificates/ProfessionsNewReneworUpdate/Telemedicine
- Jaspers L, Wolters B, Cooper C, et al. Testosterone therapy via telemedicine vs in-person care: 12-month outcomes from a national cohort. JAMA Netw Open. 2023. https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2801085
- Washington State Department of Health. Advanced registered nurse practitioner prescribing authority. https://www.doh.wa.gov/LicensesPermitsandCertificates/ProfessionsNewReneworUpdate/NursePractitionerAdvancedRegisteredNursePractitioner
- Wang C, Ilani N, Arver S, et al. Comparison of the pharmacokinetics of a novel subcutaneous testosterone enanthate autoinjector versus testosterone enanthate IM injections. J Clin Endocrinol Metab. 2011;96(8):2421-2432. https://pubmed.ncbi.nlm.nih.gov/21752882/
- Drug Enforcement Administration. Electronic prescriptions for controlled substances. https://www.deadiversion.usdoj.gov/ecomm/e_rx/
- US Food and Drug Administration. Compounding laws and policies. https://www.fda.gov/drugs/human-drug-compounding/compounding-laws-and-policies
- Washington State Health Care Authority. Prior authorization: testosterone therapy. https://www.hca.wa.gov/billers-providers-partners/prior-authorization-claims-and-billing/testosterone-therapy
- Washington State Legislature. RCW 48.43.835: Step therapy. https://app.leg.wa.gov/rcw/default.aspx?cite=48.43.835
- American Society for Reproductive Medicine Practice Committee. Testosterone therapy in men with hypogonadism. Fertil Steril. 2020. https://www.asrm.org/practice-guidance/practice-committee-documents/testosterone-therapy-in-men-with-hypogonadism/